NO904921D0 - Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater. - Google Patents

Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.

Info

Publication number
NO904921D0
NO904921D0 NO904921A NO904921A NO904921D0 NO 904921 D0 NO904921 D0 NO 904921D0 NO 904921 A NO904921 A NO 904921A NO 904921 A NO904921 A NO 904921A NO 904921 D0 NO904921 D0 NO 904921D0
Authority
NO
Norway
Prior art keywords
gangliosid
procedure
modified
preparation
functional derivatives
Prior art date
Application number
NO904921A
Other languages
English (en)
Other versions
NO174775C (no
NO904921L (no
NO174775B (no
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of NO904921D0 publication Critical patent/NO904921D0/no
Publication of NO904921L publication Critical patent/NO904921L/no
Publication of NO174775B publication Critical patent/NO174775B/no
Publication of NO174775C publication Critical patent/NO174775C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO904921A 1989-11-14 1990-11-13 Analogifremgangsmåte til fremstilling av modifiserte gangliosider og deres funksjonelle derivater NO174775C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04855489A IT1238346B (it) 1989-11-14 1989-11-14 Gangliosidi modificati e loro derivati funzionali.

Publications (4)

Publication Number Publication Date
NO904921D0 true NO904921D0 (no) 1990-11-13
NO904921L NO904921L (no) 1991-05-15
NO174775B NO174775B (no) 1994-03-28
NO174775C NO174775C (no) 1994-07-06

Family

ID=11267289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904921A NO174775C (no) 1989-11-14 1990-11-13 Analogifremgangsmåte til fremstilling av modifiserte gangliosider og deres funksjonelle derivater

Country Status (19)

Country Link
US (2) US5264424A (no)
EP (1) EP0433112B1 (no)
JP (1) JPH03170491A (no)
KR (1) KR910009716A (no)
CN (1) CN1033031C (no)
AR (1) AR246527A1 (no)
AT (1) ATE172737T1 (no)
AU (1) AU645766B2 (no)
BR (1) BR9005758A (no)
CA (1) CA2029974A1 (no)
DE (1) DE69032722T2 (no)
ES (1) ES2124214T3 (no)
FI (1) FI905628A7 (no)
HU (1) HU210744B (no)
IL (1) IL96344A0 (no)
IT (1) IT1238346B (no)
NO (1) NO174775C (no)
NZ (1) NZ236057A (no)
PL (1) PL287756A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407072B1 (en) * 1988-12-02 2002-06-18 Fidia S.P.A. Lysoganglioside derivatives
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1239060B (it) * 1990-05-04 1993-09-20 Fidia Spa Processo per la modulazione selettiva dell'espressione e della funzione di un determinante sulla superficie cellulare attraverso appropriati agenti chimici
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1267955B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati solfatati dei lisogangliosidi
US5849717A (en) * 1993-03-04 1998-12-15 Fidia S.P.A. O-sulfated gangliosides and lyso-ganglioside derivatives
IT1267956B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati o-solfatati di gangliosidi e lisogangliosidi
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
WO2003099272A1 (en) 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
JP2006508986A (ja) 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
WO2004080960A2 (en) 2003-03-06 2004-09-23 Neose Technologies Inc. Methods and compositions for the enzymatic synthesis of gangliosides
WO2005033700A1 (ja) * 2003-10-03 2005-04-14 Takeda Pharmaceutical Company Limited インスリン抵抗性改善剤のスクリーニング方法
US7798041B2 (en) * 2004-04-15 2010-09-21 Milwaukee Electric Tool Corporation Miter adjustment assembly for a saw
EP1814569A2 (en) * 2004-11-09 2007-08-08 Neose Technologies, Inc. Glycolipids
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
AU2008272785B2 (en) * 2007-07-03 2014-06-12 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
WO2009006620A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
CN109721632B (zh) * 2017-10-27 2023-10-31 齐鲁制药有限公司 一种高纯度神经节苷脂gm1及其制备方法
US12239652B2 (en) * 2018-08-24 2025-03-04 Industry-Academic Cooperation Foundation, Yonseluniversity Composition for preventing or treating muscular diseases, or for improving muscular functions, containing ganglioside

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1046051B (it) * 1975-08-13 1980-06-30 Fidia Spa Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi

Also Published As

Publication number Publication date
AR246527A1 (es) 1994-08-31
NO174775C (no) 1994-07-06
US5424294A (en) 1995-06-13
JPH03170491A (ja) 1991-07-24
NZ236057A (en) 1994-09-27
AU6662490A (en) 1991-05-23
KR910009716A (ko) 1991-06-28
EP0433112A1 (en) 1991-06-19
CN1033031C (zh) 1996-10-16
ES2124214T3 (es) 1999-02-01
IT8948554A0 (it) 1989-11-14
HU210744B (en) 1995-07-28
PL287756A1 (en) 1991-12-02
IL96344A0 (en) 1991-08-16
NO904921L (no) 1991-05-15
NO174775B (no) 1994-03-28
CN1051912A (zh) 1991-06-05
IT1238346B (it) 1993-07-13
HUT55403A (en) 1991-05-28
ATE172737T1 (de) 1998-11-15
EP0433112B1 (en) 1998-10-28
BR9005758A (pt) 1991-09-24
DE69032722D1 (de) 1998-12-03
CA2029974A1 (en) 1991-05-15
AU645766B2 (en) 1994-01-27
FI905628A0 (fi) 1990-11-14
FI905628A7 (fi) 1991-05-15
DE69032722T2 (de) 1999-07-08
US5264424A (en) 1993-11-23
IT8948554A1 (it) 1991-05-14

Similar Documents

Publication Publication Date Title
NO904921L (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
NO881344L (no) Fremgangsmaate til fremstilling av kvaternaere esteraminer og deres anvendelse.
NO892083L (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
NO893076D0 (no) Fremgangsmaate for fremstilling av aminomethyloxooxa-zolidinylarylbenzenderivater.
NO902750D0 (no) Fremgangsmaate til fremstilling av 3,5,6-substituerte derivater av 1,2-0-isopropyliden-alfa-glukofuranose og mellomprodukter for fremstilling av derivatene.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
NO903275D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO905444D0 (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO882940D0 (no) Fremgangsmaate for fremstilling av castanosperminestere og glycosider.
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO901690L (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO904805D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO903484D0 (no) Substituerte pyrazinderivater og fremgangsmaate for deres fremstilling.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO901732D0 (no) Fremgangsmaate for fremstilling av 4-alkoksyalkyl-4-aminofenylpiperidiner og derivater derav.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO892813D0 (no) Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater.